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A B S T R A C T
Background: We present a deep neck infection associated with mediastinitis treated with VAC therapy.
In this case we encountered exposure of the carotid sheath, and protected with GELFOAM® (Pﬁzer®)
sponge and ACTICOAT FLEX 3® (Smith&Nephew®), as an alternative to petroleum gauze.
Case summary: A 29-year-old female with deep neck abscess and mediastinitis involving carotid sheath.
Treated with VAC therapy, right thoracotomy and left thoracoscopy with decortication. During the VAC
changes carotid sheath was covered by a layer of Gelfoam® and Acticoat ﬂex3®. A total of 3 changes
were performed with direct wound closure with no evidence of vascular direct injury.
Conclusion: The present case demonstrates that alternative dressing choices such as GELFOAM® and
ACTICOAT FLEX3® can potentially be used instead of the classic petroleumgauze for Negative Pressure Therapy
for wounds with exposed vessels. More prospective randomized trials should be performed to ensure this
proposal safety. We believe that themicroporous layer decreases the direct negative pressure in the vessels.
We did not ﬁnd complications related to this treatment, but we cannot assume they are nonexistent.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Vacuum assisted closure (VAC) was introduced by Argenta and
Morykwas in 1997 [1]. It is a system formed by a reticulated foam
covered with an adhesive drape [2]. Negative pressure is delivered
through the system optimizing patient care. This therapy applies
negative pressure to the wound bed, resulting in 3 wound healing
beneﬁts: removing edema ﬂuid or exudate, improving blood ﬂow
in the wound bed, and stimulating cellular proliferation of pre-
parative granulation tissue [1,2].
Deep neck infection is a serious and potentially life threaten-
ing clinical condition. The mortality of such condition is very high,
reaching 40%–50%. Infection spreading toward the mediastinum
occurs along the deep cervical fascia and is facilitated by gravity and
negative intrathoracic pressure during respiration [3–5]. Surgical
drainage of purulent material, with debridement of necrotic tissue
with systemic antibiotic administration is recommended. New ev-
idence supports the application of VAC therapy and its applications
in head and neck surgery [3,6,7].
Many foams are available for negative pressure therapy. Black
(Granufoam) foam has open pores, hydrophobic and is considered
to be most effective at stimulating granulation tissue while aiding
in wound contraction [8]. White foam (VersaFoam) is a dense foam,
hydrophilic premoistened with sterile water, non-adherent, and re-
quires higher pressures starting at 125 mmHg to provide adequate
negative pressure therapy distribution, unfortunately only comes
in 1 size [8]. Black (Granufoam) Silver foam has the same speciﬁ-
cations than black foam adding silver antimicrobial properties [9].
Contraindications of VAC therapy are: malignancy in the wound,
untreated osteomyelitis, nonenteric and unexplored ﬁstulas, ne-
crotic tissue with eschar present and sensitivity to silver. Other
relative contraindications are exposed blood vessels, anastomotic
sites, organs or nerves [2].
In advanced deep neck infection carotid sheath can be in-
volved. In this scenario carotid sheath can be protected by multiple
layers of petroleum gauze. The minimally porous petroleum gauze
decreases direct negative pressure on the area of the carotid sheath
and reduces de risk of vascular injury [2,10].
Other dressings and materials unexplored in infected wounds
with exposure of blood vessels. Gelatin Foams date back to 1945
introduced by Correll andWise. They are manufactured from animal
skin whipped and baked into its sponge form [11]. Multiple pre-
sentations are available: ﬁlm, sponge or powder [11]. GELFOAM®
sterile compressed sponge is a medical device intended for
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application to bleeding surfaces as a hemostatic. It is a water-
insoluble, off-white, nonelastic, porous pliable product prepared from
puriﬁed porcine skin [12]. Its mode of action is not fully under-
stood, its effect appears to bemore physical than the result of altering
the blood clotting mechanism. Jenkins et al. theorized that clot-
ting effect of GELFOAM® may be due to release of thromboplastin
from platelets, occurring when platelets entering the sponge become
damaged by contact with the walls of its myriad of interstices [12].
It is completely absorbed with little tissue reaction within four to
six weeks. When applied to bleeding nasal rectal or vaginal mucosa
liqueﬁes within two to ﬁve days [12].
Antimicrobial barrier dressings as ACTICOAT® provide fast acting
antimicrobial action. This technology was developed to form the
dressing interface that comes into direct contact with the wound
surface [13]. ACTICOAT FCLEX 3® dressing consists of a ﬂexible, low
adherent polyester layer coated with nanocrystalline silver [14].
ACTICOAT dressings release the positively charged silver ion (Ag+).
SILCRYST silver also contains Ag0 which is present in the tiny atomic
cluster and can be solubilized. Data suggest that as a result of this
antimicrobial action ACTICOAT® may be responsible for modulat-
ing protease activity to promote healing [8,14,15].
We present a deep neck infection associated with mediastini-
tis treated with VAC therapy. In this case we encountered exposure
of the carotid sheath, and protected with GELFOAM® (Pﬁzer®)
sponge and ACTICOAT FLEX 3® (Smith&Nephew®), as an alterna-
tive to petroleum gauze.
2. Presentation case
A 29-year-old female presented with eight days jaw pain, with
irradiation to right auricular region. She already was treated with
pain killers and antibiotics with no positive response. She went to
another surgeon who performed surgery draining submandibular
space abscess. Twomore interventions were necessary with no pos-
itive response. In the last procedure a VAC systemwas installed and
was referred to our Head and Neck Clinic.
The ﬁrst 48 hrs is continuous at 125 mmHg and the last 24 hrs
is intermittent therapy 5 minutes on and 2 minutes off. We did not
consider the use of wet-to-wet or wet-to-dry dressings, the loca-
tion and exposure of carotid sheath. The change of the dressings
might be uncomfortable for the patient and require experimented
wound care specialists who are not available during night shift in
our institution.
We received this case with a functional VAC system we started
on piperacillin tazobactam. She presented signs of septic status with
no need of vasopressors. In oral exam we found evidence of dental
caries in two inferior secondmolars. And we found a functional neg-
ative pressure therapy system. In the thoracic examination right
pleural effusion syndromewas evidentwith no other relevant ﬁndings.
The laboratory ﬁndings: white blood cell count of 14.23 (×109/
L) with procalcitonin 1.6 ng/ml. CAT scan was performed reporting
deep neck abscess with anterior and posterior mediastinal extension.
We extended the dissection to all the cervical spaces, and changed
the VAC system. We cultured the wound with no pathogen iso-
lated. Simultaneously a Right thoracotomy with drainage of
mediastinum by pleurostomy was performed by Thorax Surgery
Clinic. The carotid space was explored and later was protected with
Gelfoam® and Acticoat ﬂex 3® to decrease the negative pressure
and prevent vascular injury (Fig. 1). The reticulated foam was in-
stalled over the Acticoat ﬂex 3 and ﬁnally the drapes to seal the
wound. The negative pressure was adjusted to 125 mmHg.
Follow-up and outcomes: Left thoracoscopy and decortication
was necessary because X-rays demonstrated signs of empyema, cor-
roborated by CAT scan.
Due to the odontogenic origin of the deep neck abscess, two in-
ferior molars were removed by the service of maxillofacial surgery.
After 3 changes of negative pressure system the wound was closed
(Fig. 2), the left and right thoracostomies were retired and the patient
was discharged without major complications.
3. Discussion
Treatment of deep neck infection should be aggressive, protect-
ing airway, adequate antibiotic treatment and surgical abscess
drainage [14]. Indications of Surgery include airway impairment,
septicemia, descending infection, diabetes mellitus, or no clinical
improvement within 48 hrs from parenteral antibiotic administra-
tion [3,8]. In addition abscesses >3 cm in diameter that involve
prevertebral, anterior visceral or carotid spaces, or that involve more
than two spaces, should be surgically drained [15].
New evidence suggests that negative pressure systems are su-
perior to conventional deep neck treatment [7]. Gallo et al. [3]
presented a similar case with deep neck infection and VAC therapy
opportunely, with no need of thoracotomy. Unfortunately in our case
mediastinal spread was inevitable due to the previous treatment.
The optimal therapy is thewhite foam to protect the blood vessels
plus either with silver foam on the top or black foam. The disad-
vantages are the high cost and the waste of material in each change
of dressing.Wet-to-dry dressings and openwoundmanagementmay
be lower in cost, but take more time and trained staff is required.
In life threatening conditions as mediastinitis or deep neck abscess,
reducing time of healing it is crucial. We propose a mid cost alter-
native to white foam and silver foam.
GELFOAM®, when applied to bleeding nasal rectal or vaginal
mucosa, liqueﬁes within two to ﬁve days. In other wound sites it
is completely absorbed with little tissue reaction within four to six
weeks. In addition, the negative pressure therapy was changed every
72 hrs and we still found the previous GELFOAM®. The size
Fig. 1. The carotid space was explored and later was protected with Gelfoam and
Acticoat ﬂex 3 to decrease the negative pressure and prevent vascular injury.
Fig. 2. Final result after 3 negative wound closure changes.
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available is smaller than white foam, making it a suitable option
with the carotid sheath, wasting less material. In this speciﬁc sce-
nario lowering the cost with probably same effectiveness. There is
no literature with combined use of GELFOAM® and negative pres-
sure therapy related with blood vessel exposure.
Vessel exposure is a relative limitation to the negative pres-
sure therapy. Many authors prefer to put the negative pressure
distant to the exposed and fragile vessels [10,15–17]. Other options
include petroleum gauze over the carotid sheath to decrease the neg-
ative pressure and prevent vascular damage [2,10]. We alternatively
used GELFOAM® (Pﬁzer®) sponge and ACTICOAT FLEX 3®
(Smith&Nephew®) succeeding in preventing vascular injury.
4. Conclusion
The present case demonstrates that alternative dressing choices
such as GELFOAM® and ACTICOAT FLEX3® can potentially be used
instead of the classic petroleum gauze for Negative Pressure Therapy
for woundswith exposed vessels. More prospective randomized trials
should be performed to ensure this proposal safety. We believe that
the microporous layer decreases the direct negative pressure in the
vessels. We did not ﬁnd complications related to this treatment, but
we cannot assume they are nonexistent.
Ethical approval
Verbal and written consent was granted by the patient.
Funding
This paper was not founded by any institution.
Author contribution
Marco Aurelio Rendón Medina: concept of the paper.
Alondra Ruelas Ayala: text reviser.
Edgar Montes de Oca Durán: lead investigator and tutor.
Conﬂict of interest statement
The authors whose names are listed immediately below certify
that they have NO aﬃliations with or involvement in any organi-
zation or entity with any ﬁnancial interest (such as honoraria;
educational grants; participation in speakers’ bureaus; member-
ship, employment, consultancies, stock ownership, or other equity
interest; and expert testimony or patent-licensing arrangements),
or non-ﬁnancial interest (such as personal or professional relation-
ships, aﬃliations, knowledge or beliefs) in the subject matter or
materials discussed in this manuscript.
Guarantor
Marco Aurelio Rendón Medina
Alondra Ruelas Ayala
Edgar Montes de Oca Durán.
Research registration UIN
Case report, and no new therapies were used.
Acknowledgement
We would like to acknowledge the support from Benito
Vargas Abrego M.D. consultant thoracic surgeon for his opportune
support.
Appendix: Supplementary material
Supplementary data to this article can be found online at
doi:10.1016/j.ijso.2016.09.003.
References
[1] Argenta LC, Morykwas MJ. Vaccum-assisted closure: a newmethod for wound
control and treatment: clinical experience. Ann Plat Surg 1997;38(6):563–77.
[2] 3M™ and Cavilon™, V.A.C. therapy clinical guidelines. A reference source for
clinicians. San Antonio, Tx: KCI, The Clinical Advantage, USA, <www.kci
-medical.com.au>; 2003 [accessed 22.08.16].
[3] Gallo O, Deganello A, Meccariello G, Spina R, Peris A. Vacuum-assisted closure
for managing neck abscesses involving the mediastinum. Laryngoscope
2012;122:785–8.
[4] Wang LF, KuoWR, Tsai SM, Huang KJ. Characterizations of life-threatening deep
cervical space infections: a review of one hundred ninety-six cases. Am J
Otolaryngol 2003;24:111–17.
[5] Parhiscar A, Har-el G. Deep neck abscess: a retrospective review of 210 cases.
Ann Otol Rhinol Laryngol 2001;110:1051–4.
[6] Govea-Camacho LH, Astudillo-Carrera A, Hermosillo-Sandoval JM,
Rodríguez-Reynoso S, González-Ojeda A, Fuentes-Orozco C. Ompacto del manejo
con cierre asistido al vacio en asbestos profundos de cuello. Cir Cir
2016;<http://dx.doi.org/10.1016/j.circir.2015.12.004>.
[7] Hyun SY, Oh HK, Ryu JY, Kim JJ, Cjo JY, Kim HM. Closed suction drainage for
Deep neck infections. J Carniomaxillofac Surg 2014;42(6):751–6.
[8] Debelak CS, Estapa A, Piercey A, Diaz J. Wound V.A.C. – KCI Protocol. Emergency
General Surgery Service. Vanderbilt University Medical Center. 2004.
[9] Garrigós X, Guisantes E, Oms L, Mato R. Combination of different V.A.C. therapy
services for the closure of complex abdominal defects. Cir Plást Iberolatinoam
2014;40(3):243–51.
[10] Frankel JK, Rezaee RP, Harvey DJ, McBeath ER, Zender CA, Lavertu P. Head Neck
2015;37:E157–60. doi:10.10027HED.
[11] Surgery A.O.F., Associated A., Professionals M. A Comprehensive Review
of Topical Hemostatic Agents. 2009;(January 2016). doi:10.1097/SLA
.0b013e3181c3bcca.
[12] Jenkins HP, Janda R, Clarke J. Clinical and experimental observations on the use
of gelatin sponge or foam. Surgery 1946;20:124–32.
[13] Ag A., Rehabil B.C. ACTICOATTM AND ALLEVYNTM Ag made easy. Wounds Int
2011;2(2):7–12.
[14] Smith & Nephew. ActicoatTM ﬂex 3, <www.smith-nephew.com>; 2009
[accessed 22.08.16], 33716.
[15] Yang YH, Jemg SF, Hsieh CH, Feng GM, Chen CC. Vacuum-assisted closure for
complicated wounds in head and neck region after reconstruction. J Plast
Reconstr Aesthet Surg 2013;66:e209–16.
[16] Gabriel A, Shores J, Bernstein B, de Leon J, Kamepalli R, Wolvos T, et al. A clinical
review wound treatment with vacuum assisted closure (V.A.C.R) therapy:
experience and case series. Int Wound J 2009;6(Suppl. 2):1–25.
[17] Wei FC, Dermirkan F, Chen HC, Chuang DC, Chen SH, Lin CH, et al. The outcome
of failed free ﬂaps in head and neck and extremity reconstruction: what is next
in the reconstructive ladder? Plast Reconst Surg 2001;108(5):1154–60,
Discussion 1161–1162.
22 M.A.R. Medina et al. / International Journal of Surgery Open 5 (2016) 20–22
